Sigma-1 receptor and the control of inflammation
Author:
orcid.org/0000-0002-0342-8454
Rosen, Dorian, Pharmacology - School of Medicine, University of Virginia
![ORCID icon](/assets/orcid-cb273c1ff10d304ce1b6108a172bfd1660561e7fd8133b083cd66ee0f4a0a944.png)
Rosen, Dorian, Pharmacology - School of Medicine, University of Virginia
Advisor:
Gaultier, Alban, MD-NESC Neuroscience, University of Virginia
Gaultier, Alban, MD-NESC Neuroscience, University of Virginia
Abstract:
The endoplasmic reticulum resident protein sigma-1 receptor is druggable and controls inflammatory outcomes during acute inflammatory insults.
Degree:
PHD (Doctor of Philosophy)
PHD (Doctor of Philosophy)
Keywords:
endoplasmic reticulum, sigma-1 receptor, inflammation, LPS, sepsis, multiple sclerosis, lipopolysaccharide, fecal induced peritonitis, fluvoxamine, XBP1, IRE1
endoplasmic reticulum, sigma-1 receptor, inflammation, LPS, sepsis, multiple sclerosis, lipopolysaccharide, fecal induced peritonitis, fluvoxamine, XBP1, IRE1
Language:
English
English
Issued Date:
2019/05/01
2019/05/01